Cargando…

The x(c)(−) cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance

The x(c)(−) cystine transporter enhances biosynthesis of glutathione, a tripeptide thiol important in drug resistance and cellular defense against oxidative stress, by enabling cellular uptake of cystine, a rate-limiting precursor. Because it is known to regulate glutathione levels and growth of var...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo, M, Ling, V, Wang, Y Z, Gout, P W
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527809/
https://www.ncbi.nlm.nih.gov/pubmed/18648370
http://dx.doi.org/10.1038/sj.bjc.6604485
_version_ 1782158841633308672
author Lo, M
Ling, V
Wang, Y Z
Gout, P W
author_facet Lo, M
Ling, V
Wang, Y Z
Gout, P W
author_sort Lo, M
collection PubMed
description The x(c)(−) cystine transporter enhances biosynthesis of glutathione, a tripeptide thiol important in drug resistance and cellular defense against oxidative stress, by enabling cellular uptake of cystine, a rate-limiting precursor. Because it is known to regulate glutathione levels and growth of various cancer cell types, and is expressed in the pancreas, we postulate that it is involved in growth and drug resistance of pancreatic cancer. To examine this, we characterised expression of the x(c)(−) transporter in pancreatic cancer cell lines, MIA PaCa-2, PANC-1 and BxPC-3, as subjected to cystine-depletion and oxidative stress. The results indicate that these cell lines depend on x(c)(−)-mediated cystine uptake for growth, as well as survival in oxidative stress conditions, and can modulate x(c)(−) expression to accommodate growth needs. Immunohistochemical analysis showed that the transporter was differentially expressed in normal pancreatic tissues and overexpressed in pancreatic cancer tissues from two patients. Furthermore, gemcitabine resistance of cells was associated with elevated x(c)(−) expression and specific x(c)(−) inhibition by monosodium glutamate led to growth arrest. The results suggest that the x(c)(−) transporter by enhancing glutathione biosynthesis plays a major role in pancreatic cancer growth, therapy resistance and represents a potential therapeutic target for the disease.
format Text
id pubmed-2527809
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-25278092009-09-11 The x(c)(−) cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance Lo, M Ling, V Wang, Y Z Gout, P W Br J Cancer Translational Therapeutics The x(c)(−) cystine transporter enhances biosynthesis of glutathione, a tripeptide thiol important in drug resistance and cellular defense against oxidative stress, by enabling cellular uptake of cystine, a rate-limiting precursor. Because it is known to regulate glutathione levels and growth of various cancer cell types, and is expressed in the pancreas, we postulate that it is involved in growth and drug resistance of pancreatic cancer. To examine this, we characterised expression of the x(c)(−) transporter in pancreatic cancer cell lines, MIA PaCa-2, PANC-1 and BxPC-3, as subjected to cystine-depletion and oxidative stress. The results indicate that these cell lines depend on x(c)(−)-mediated cystine uptake for growth, as well as survival in oxidative stress conditions, and can modulate x(c)(−) expression to accommodate growth needs. Immunohistochemical analysis showed that the transporter was differentially expressed in normal pancreatic tissues and overexpressed in pancreatic cancer tissues from two patients. Furthermore, gemcitabine resistance of cells was associated with elevated x(c)(−) expression and specific x(c)(−) inhibition by monosodium glutamate led to growth arrest. The results suggest that the x(c)(−) transporter by enhancing glutathione biosynthesis plays a major role in pancreatic cancer growth, therapy resistance and represents a potential therapeutic target for the disease. Nature Publishing Group 2008-08-05 2008-07-22 /pmc/articles/PMC2527809/ /pubmed/18648370 http://dx.doi.org/10.1038/sj.bjc.6604485 Text en Copyright © 2008 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Translational Therapeutics
Lo, M
Ling, V
Wang, Y Z
Gout, P W
The x(c)(−) cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance
title The x(c)(−) cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance
title_full The x(c)(−) cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance
title_fullStr The x(c)(−) cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance
title_full_unstemmed The x(c)(−) cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance
title_short The x(c)(−) cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance
title_sort x(c)(−) cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance
topic Translational Therapeutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527809/
https://www.ncbi.nlm.nih.gov/pubmed/18648370
http://dx.doi.org/10.1038/sj.bjc.6604485
work_keys_str_mv AT lom thexccystineglutamateantiporteramediatorofpancreaticcancergrowthwitharoleindrugresistance
AT lingv thexccystineglutamateantiporteramediatorofpancreaticcancergrowthwitharoleindrugresistance
AT wangyz thexccystineglutamateantiporteramediatorofpancreaticcancergrowthwitharoleindrugresistance
AT goutpw thexccystineglutamateantiporteramediatorofpancreaticcancergrowthwitharoleindrugresistance
AT lom xccystineglutamateantiporteramediatorofpancreaticcancergrowthwitharoleindrugresistance
AT lingv xccystineglutamateantiporteramediatorofpancreaticcancergrowthwitharoleindrugresistance
AT wangyz xccystineglutamateantiporteramediatorofpancreaticcancergrowthwitharoleindrugresistance
AT goutpw xccystineglutamateantiporteramediatorofpancreaticcancergrowthwitharoleindrugresistance